Associations of serum glucagon levels with glycemic variability in type 1 diabetes with different disease durations
- PMID: 29916102
- DOI: 10.1007/s12020-018-1641-1
Associations of serum glucagon levels with glycemic variability in type 1 diabetes with different disease durations
Abstract
Purpose: Glucagon has been recognized as a pivotal factor implicated in the pathophysiology ofdiabetes. The purpose of this study is to investigate the dynamic secretion levels of serum glucagon (GLA) in patients with type 1 diabetes mellitus (T1DM) with different courses of disease, and to analyze its correlation with blood glucose fluctuation.
Methods: This observational study included 55 T1DM patients and divided into 3 groups according to the courses of disease. Group 1(the disease duration <1 year), Group 2(1≤the disease durations≤5), 3(the disease durations >5 years). All patients underwent a 100g standard steamed buns meal test,measuring the levels of serum glucose, glucagon, insulin, C-peptide in different points of time, and 48 of the total patients used continuous glucose monitoring system (CGMS) to monitor blood glucose.
Results: The fasting glucagon level in Group 1 was significantly higher than it in Group 2. Furthermore, the GLA1h, the GLA3h and the AUCGLA0-3h in Group 1 were greatly larger than those in Group 3. Referring to glycemic variability, the LBGI, AUC of hypoglycemia, the percentage of hypoglycemia time andthe times of nocturnal hypoglycemia in Group 1 were significantly lower than those in Group 3. Moreover,the fasting glucagon level was the independent factors to SD and MAGE. The AUCGLA0-3h were negatively correlated with MODD, LBGI, GRADE-hypo and AUC of nocturnal hypoglycemia.
Conclusions: It is concluded that glucagon secretory function impairs with duration of type 1 diabetes extended and correlates to glycemic fluctuation, especially hypoglycemia.
Keywords: Continuous glucose monitoring system; Glucagon; Glycemia variability; Standard steamed buns meal test.
Similar articles
-
Association between time in range, a novel measurement of glycemic control and islet secretory function in chinese patients with type 2 diabetes mellitus-An observational study.Diabetes Res Clin Pract. 2021 Mar;173:108684. doi: 10.1016/j.diabres.2021.108684. Epub 2021 Feb 1. Diabetes Res Clin Pract. 2021. PMID: 33539867
-
Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes.Diabetes Res Clin Pract. 2019 Dec;158:107904. doi: 10.1016/j.diabres.2019.107904. Epub 2019 Oct 28. Diabetes Res Clin Pract. 2019. PMID: 31672500
-
Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycemia in T1DM.J Clin Endocrinol Metab. 2018 Apr 1;103(4):1408-1417. doi: 10.1210/jc.2017-01836. J Clin Endocrinol Metab. 2018. PMID: 29408994
-
Nocturnal blood glucose control in type I diabetes mellitus.Diabetes Care. 1993 Dec;16 Suppl 3:71-89. doi: 10.2337/diacare.16.3.71. Diabetes Care. 1993. PMID: 8299480 Review.
-
Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.Diabetes Technol Ther. 2017 Jun;19(S3):S25-S37. doi: 10.1089/dia.2017.0035. Diabetes Technol Ther. 2017. PMID: 28585879 Free PMC article. Review.
Cited by
-
The Role of Glucagon in Glycemic Variability in Type 1 Diabetes: A Narrative Review.Diabetes Metab Syndr Obes. 2021 Dec 21;14:4865-4873. doi: 10.2147/DMSO.S343514. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 34992395 Free PMC article. Review.
-
Advances in clinical research on glucagon.Diabetol Int. 2024 Mar 23;15(3):353-361. doi: 10.1007/s13340-024-00705-w. eCollection 2024 Jul. Diabetol Int. 2024. PMID: 39101175 Free PMC article. Review.
-
Association of sleep quality with glycemic variability assessed by flash glucose monitoring in patients with type 2 diabetes.Diabetol Metab Syndr. 2021 Sep 23;13(1):102. doi: 10.1186/s13098-021-00720-w. Diabetol Metab Syndr. 2021. PMID: 34556157 Free PMC article.
-
Mitigation of Rebound Hyperglycemia With Real-Time Continuous Glucose Monitoring Data and Predictive Alerts.J Diabetes Sci Technol. 2022 May;16(3):677-682. doi: 10.1177/1932296820982584. Epub 2021 Jan 5. J Diabetes Sci Technol. 2022. PMID: 33401946 Free PMC article. Clinical Trial.
-
Association between Hemoglobin Glycation Index and NAFLD in Chinese Nondiabetic Individuals.Can J Gastroenterol Hepatol. 2019 Dec 19;2019:8748459. doi: 10.1155/2019/8748459. eCollection 2019. Can J Gastroenterol Hepatol. 2019. PMID: 31929982 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical